Stock CRAD B C-RAD AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials C-Rad AB

Equities

CRAD B

SE0002016352

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm
Other stock markets
 11:14:20 2024-04-26 am EDT 		5-day change 1st Jan Change
38.7 SEK +0.65% Intraday chart for C-Rad AB -3.49% -8.29%
Apr. 24 C-Rad AB Appoints Mats Thorén as Board Member CI
Mar. 25 C-RAD Announces Resignation of Christoffer Herou as CFO, Effective September 25, 2024 CI

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,622 1,880 1,287 1,421 1,303 - -
Enterprise Value (EV) 1 1,622 1,758 1,165 1,292 1,101 1,017 913.7
P/E ratio 112 x 75.3 x 173 x 31 x 18.5 x 13.2 x 10.8 x
Yield - - - - - - -
Capitalization / Revenue - 7.2 x 4.27 x 3.35 x 2.7 x 2.34 x 2.06 x
EV / Revenue - 6.73 x 3.87 x 3.04 x 2.28 x 1.83 x 1.44 x
EV / EBITDA - 38.5 x 32.2 x 19.5 x 11.2 x 7.57 x 5.64 x
EV / FCF - 143 x -760 x 78.8 x 15.2 x 12.3 x 8.93 x
FCF Yield - 0.7% -0.13% 1.27% 6.6% 8.14% 11.2%
Price to Book - 8.13 x 5.31 x 5.06 x 3.71 x 2.9 x 2.29 x
Nbr of stocks (in thousands) 33,659 33,752 33,767 33,678 33,678 - -
Reference price 2 48.20 55.70 38.10 42.20 38.70 38.70 38.70
Announcement Date 4/16/21 1/27/22 1/26/23 2/8/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 261.2 301.3 424.6 482.9 556.6 633.1
EBITDA 1 - 45.7 36.2 66.4 98.38 134.4 162
EBIT 1 - 36 26.1 57.5 87.98 123.4 150.6
Operating Margin - 13.78% 8.66% 13.54% 18.22% 22.17% 23.79%
Earnings before Tax (EBT) 1 - 35.7 21.5 57.2 88.69 124.4 152
Net income 1 14.36 25.1 7.5 46.1 70.42 98.77 120.7
Net margin - 9.61% 2.49% 10.86% 14.58% 17.74% 19.07%
EPS 2 0.4300 0.7400 0.2200 1.360 2.090 2.931 3.582
Free Cash Flow 1 - 12.3 -1.532 16.4 72.6 82.8 102.3
FCF margin - 4.71% -0.51% 3.86% 15.03% 14.88% 16.16%
FCF Conversion (EBITDA) - 26.91% - 24.7% 73.8% 61.59% 63.14%
FCF Conversion (Net income) - 49% - 35.57% 103.09% 83.84% 84.75%
Dividend per Share 2 - - - - - - -
Announcement Date 4/16/21 1/27/22 1/26/23 2/8/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 63.2 77.4 56.3 62.7 83.5 98.8 84.4 90.6 111.2 138.4 106.9 109 123.7 143.3
EBITDA 1 11.3 17.4 2.8 3.3 17.1 13 8.7 9.6 21 27 16.28 17.75 30.51 33.85
EBIT 1 8.8 14.9 0.2 0.8 14.6 10.5 6.4 7.4 18.9 24.8 13.68 15.15 27.91 31.25
Operating Margin 13.92% 19.25% 0.36% 1.28% 17.49% 10.63% 7.58% 8.17% 17% 17.92% 12.8% 13.9% 22.56% 21.81%
Earnings before Tax (EBT) 1 8.7 14.9 0.1 0.8 14.3 6 6.3 7.3 18.9 24.7 13.84 15.32 28.08 31.45
Net income 1 4.9 11.4 -1.2 -2.9 7.1 4.2 3.2 5.4 10.9 26.5 10.99 12.17 22.3 24.97
Net margin 7.75% 14.73% -2.13% -4.63% 8.5% 4.25% 3.79% 5.96% 9.8% 19.15% 10.28% 11.17% 18.02% 17.43%
EPS 2 0.1500 0.3400 -0.0400 -0.0900 0.2100 0.1200 0.1000 0.1600 0.3200 0.7800 0.3261 0.3610 0.6616 0.7409
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 10/28/21 1/27/22 5/6/22 7/21/22 10/28/22 1/26/23 5/5/23 7/20/23 10/27/23 2/8/24 - - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 - 122 122 129 203 286 390
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - 12.3 -1.53 16.4 72.6 82.8 102
ROE (net income / shareholders' equity) - 46.6% 3.8% 17.6% 22.2% 24.6% 23.6%
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 - 6.850 7.180 8.340 10.40 13.30 16.90
Cash Flow per Share - - - - - - -
Capex 1 - 5.8 11.2 16.9 18.1 18.4 19
Capex / Sales - 2.22% 3.72% 3.98% 3.75% 3.31% 3%
Announcement Date 4/16/21 1/27/22 1/26/23 2/8/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for C-Rad AB

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
38.7 SEK
Average target price
58 SEK
Spread / Average Target
+49.87%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
C-RAD AB Stock C-Rad AB
-8.29% 119M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
RESMED, INC. Stock ResMed, Inc.
+26.76% 32.03B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. CRAD B Stock
  4. Financials C-Rad AB